Release Date: 01/05/15 11:35 Summary: Landmark Acquisition Price Sensitive: Yes Download Document 3.09MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%